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Introduction

45
Chronic kidney disease patients are at high risk for hepatitis B virus (HBV) infection 46 due to increased exposure to blood products, shared hemodialysis equipment, 47 frequent skin breaches, and immunodeficiency. Table 2 ). Only 43.3% of patients aged ≥ 65 years presented 101 levels of anti-HBs ≥10 IU/mL, and had a worse response than those aged <65, 
Laboratory methods
166
Serological screening for HBsAg was made in all chronic kidney disease patients.
167
The response to HBV vaccination was detected by measuring anti-HBs and was 168 determined by enzyme immunoassay system using AUSAB AxSYM particles 
